The foundational science to develop an exhaled-breath test for detection of lung diseases, including lung cancer, is underway, according to new research published by a laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI).

Restore Medical announced today that it received FDA breakthrough device designation for its ContraBand heart failure treatment device.